Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG and LFCN Blocks for Recovery After Total Hip Replacement
NCT04245280Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- May 2021
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Quality of Recovery 15 at 24 hours. Started May 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04245280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04245280.